Pictet-EUR High Yield-HP CHF
Performance (in CHF)
Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.
Performance
| 1 month | -1.09% |
|---|---|
| Current year | -0.75% |
| 3 years p.a. | 2.22% |
| 5 years p.a. | 2.50% |
| 10 years p.a. | 1.23% |
| Since inception p.a. | n.a. |
Rolling performance in %
Key figures
| YTD | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Performance | -0.75% | 3.62% | 6.82% | 13.14% | 13.07% |
| Maximum profit on monthly basis | 0.87% | 1.25% | 3.42% | 5.44% | 5.44% |
| Maximum loss on monthly basis | -0.97% | -0.97% | -6.16% | -6.16% | -11.70% |
| Max drawdown | -4.66% | -4.66% | -11.14% | -17.71% | -20.70% |
| Volatility | 6.04% | 4.06% | 4.47% | 4.58% | 5.61% |
| Sharpe ratio | -0.79 | 0.26 | -0.08 | 0.27 | 0.13 |
| Maximum continuous profit in months | 2 | 10 | 10 | 10 | 10 |
| Maximum continuous loss in months | 1 | 1 | 3 | 6 | 6 |
| Positive months / profit duration in months | 3 | 11 | 24 | 40 | 71 |
| Negative months / loss duration in months | 1 | 2 | 13 | 21 | 50 |
Master data
| Fund name | Pictet-EUR High Yield-HP CHF |
|---|---|
| Fund management company | Pictet Asset Management (Europe) S.A. |
| Fund domicile | Luxembourg |
| Inception date | 04 September 2003 |
| ISIN | LU0174610443 |
| Swiss security no. | 1657965 |
| Fund currency | CHF |
| Appropriation of income | accumulating |
| Issuing commission | |
| Ongoing charges under PRIIP KID as at 07 February 2025 | 1.42% |
| End of financial year | 30 September |
| Paying agent | Bank Pictet & Cie S.A. |
| Representative in Switzerland | Pictet Asset Management S.A. |
| Fund volume as at 28 February 2025 | 435.11 Mio. CHF |
| Net asset value (NAV) as at 23 April 2025 | 349.76 CHF |
Portfolio structure
Top holdings of fund volume (in %)
| ELECTRICITE DE FRANCE SA EMTN F2F 7.50% 06.12.2198 | 1.36% | |
| 2.875% Elo Saca 1/2026 | 1.30% | |
| RAKUTEN GR 4.25%/VAR PERP RGS | 1.20% | |
| 5.375% Unicredit Spa 4/2034 | 1.18% | |
| 4.375% Teva Pharmaceutical Fin NED II 5/2030 | 1.16% |